Posted On: 10/10/2014 4:47:46 PM
Post# of 30066
Hi Aimee,
Either Gerald has a LymPro BP JV Agreement in hand - or he has very questionable timing to issue this filing now.
IMHO, to issue this with no current revenue on the books and on the back of 1-Bil. AS count increase is simply not good economics, and not shareholder respectful or friendly.
I sure hope Gerald has news on Monday morning...........I'm all for AMBS and the team, I get how long GC and John have been at this, and how much of their life blood is on the line here, but I'm not for it having been done this way..........IMHO, it would have been better after announcing sustainable revenue generating contracts.
Thanks for reading this.
All the Best, JP
Read More: http://investorshangout.com/post/view?id=2126...z3FmD08xQS
In a message dated 10/10/2014 4:17:05 P.M. Eastern Daylight Time, aimee.boutcher@amarantus.com writes:
http://www.amarantus.com/
Amarantus BioScience Holdings, Inc. has filed the following documents with the SEC:
SEC Filing Alert
8-K: Current report filing
HTML PDF
If you have any questions, or would like to contact Investor Relations, please reply to this email.
Amarantus BioScience Holdings, Inc. | 655 Montgomery Street | Suite 900 | San Francisco, CA 94111
http://www.amarantus.com/
To change your subscription preferences, please click here
=
Either Gerald has a LymPro BP JV Agreement in hand - or he has very questionable timing to issue this filing now.
IMHO, to issue this with no current revenue on the books and on the back of 1-Bil. AS count increase is simply not good economics, and not shareholder respectful or friendly.
I sure hope Gerald has news on Monday morning...........I'm all for AMBS and the team, I get how long GC and John have been at this, and how much of their life blood is on the line here, but I'm not for it having been done this way..........IMHO, it would have been better after announcing sustainable revenue generating contracts.
Thanks for reading this.
All the Best, JP
Read More: http://investorshangout.com/post/view?id=2126...z3FmD08xQS
In a message dated 10/10/2014 4:17:05 P.M. Eastern Daylight Time, aimee.boutcher@amarantus.com writes:
http://www.amarantus.com/
Amarantus BioScience Holdings, Inc. has filed the following documents with the SEC:
SEC Filing Alert
8-K: Current report filing
HTML PDF
If you have any questions, or would like to contact Investor Relations, please reply to this email.
Amarantus BioScience Holdings, Inc. | 655 Montgomery Street | Suite 900 | San Francisco, CA 94111
http://www.amarantus.com/
To change your subscription preferences, please click here
=
(0)
(0)
